Molecular and spatial epidemiology of HCV among people who inject drugs in Boston, Massachusetts

Integration of genetic, social network, and spatial data has the potential to improve understanding of transmission dynamics in established HCV epidemics. Sequence data were analyzed from 63 viremic people who inject drugs recruited in the Boston area through chain referral or time-location sampling. HCV subtype 1a was most prevalent (57.1%), followed by subtype 3a (33.9%). The phylogenetic distances between sequences were no shorter comparing individuals within versus across networks, nor by location or time of first injection. Social and spatial networks, while interesting, may be too ephemeral to inform transmission dynamics when the date and location of infection are indeterminate.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 18, 2022. ;https://doi.org/10.1101/2022 Although now curable, hepatitis C virus (HCV) infections continue to be problematic.

57
In the United States, HCV mortality has increased in recent years, while mortality for 61 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint in the sub-study of HCV-positive participants.

101
Blood specimens were centrifuged, and the serum was added to RNALater® to 102 preserve the integrity of viral RNA (RNALater; Ambion Inc., Austin, TX). Samples were 103 stored at -80°C. After thawing, viral RNA was purified and a 360-base region in the core 104 gene was amplified and sequenced to identify genotypes and produce phylogenetic trees.

105
We optimally aligned the nucleotide sequences using the CLUSTAL W program and 106 constructed a phylogenetic tree by the Neighbor-Joining method based on Kimura's two-. CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint years injecting was also divided into three categories: 0-5, 6-10, >10 years.

121
Among the 102 participants who tested positive for HCV antibodies and provided a 122 subsequent blood sample, 66 were actively infected and sequence data were obtained from is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 18, 2022. ;https://doi.org/10.1101/2022 doi: medRxiv preprint analyses were no shorter comparing sequence data within versus across networks ( Figure   162 1B). Four of the oldest injectors in the sample (individuals born in 1977 or earlier) were 163 infected with HCV genotypes 1b and 2b. Only one other individual was infected with either of 164 these two subtypes ( Figure 1B).

166
Integrating social network, spatial, and molecular data from established epidemics Our findings that HCV subtype 1a was the predominant subtype among PWID in the 178 Boston Area (57.1%), followed by subtype 3a (33.9%), differs from studies elsewhere that 179 focused on HCV among PWID. A study from New York, conducted twenty years earlier than 180 ours, found that the predominant genotypes were 1a and 1b, with 3a comprising only 5% of 181 sequences genotyped. 12 A study from Baltimore, concurrent with ours, found no evidence of 182 genotype 3a. 13 Our study population was substantially younger than those in the other two 183 studies, consistent with our aim to recruit a younger sample, but differences in genotype 184 were not associated with age. However, there were two subtypes (1b and 2b) that were . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 18, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

261
. CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 18, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022